# Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

> **NCT02021604** · PHASE1 · RECRUITING · sponsor: **Cook Children's Health Care System** · enrollment: 250 (estimated)

## Conditions studied

- Congenital Hyperinsulinism
- Insulinoma

## Interventions

- **DRUG:** Fluorodopa F 18

## Key facts

- **NCT ID:** NCT02021604
- **Lead sponsor:** Cook Children's Health Care System
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-10-09
- **Primary completion:** 2028-01
- **Final completion:** 2028-06
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02021604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02021604, "Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02021604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*